Patents Assigned to OZYMES
  • Patent number: 10227575
    Abstract: An isolated chimeric recombinant protein has cutinase activity. The protein includes a cutinase catalytic domain and a polymer binding domain operably linked by a proline/threonine-rich linker domain. The proline/threonine-rich linker domain includes at least 50% proline or threonine residues over a stretch of 15 to 55 consecutive amino acids.
    Type: Grant
    Filed: August 9, 2017
    Date of Patent: March 12, 2019
    Assignees: Ozymes, National Research Council of Canada
    Inventors: Kofi Abokitse, Peter C. K. Lau, Stephan Grosse
  • Patent number: 9752131
    Abstract: Multi-domain recombinant proteins have a cutinase catalytic domain. The cutinase catalytic domain is a modular domain, which may be combined with other protein domains that also function in a modular fashion. For example, the cutinase catalytic domain can be operably linked to a polymer binding domain via a linker domain (e.g., a threonine/proline-rich linker polypeptide). The cutinase catalytic domain can be from an endogenous cutinase having a multi-domain modular organization, such as from the actinobacterium Kineococcus radiotolerans. The recombinant proteins are used in compositions, methods and uses, such as for use in industrial applications.
    Type: Grant
    Filed: February 16, 2016
    Date of Patent: September 5, 2017
    Assignees: NATIONAL RESEARCH COUNCIL OF CANADA, OZYMES
    Inventors: Kofi Abokitse, Peter C. K. Lau, Stephan Grosse